Table 6 Definitive therapeutic choice and shunt settings in patients with diagnosed IIH after conducting telemetric ICP monitoring
ID | The Definitive Applied Therapy | VP-shunt valve pressure settings in cm H2O (differential/gravitational) on conclusion of ICP monitoring* | Number of subsequent shunt valve adjustments after surgery |
|---|---|---|---|
1 | VP Shunt (M.blue plus®) | 5/25 | 0 |
2 | ETV + Plexus chorideus coagulation | Not Applicable | 0 |
3 | Stenting of the transverse sinus | Not Applicable | 0 |
4 | VP Shunt (proSA® Shunt System) | 5/28 | 2 |
5 | VP Shunt (proSA® Shunt System) | 7/30 | 2 |
6 | VP Shunt (proSA® Shunt System) | 0/36 | 6 |
7 | VP Shunt (proSA® Shunt System) | 10/24 | 4 |
8 | Change of VP Shunt valves to proSA® Shunt System | 6/26 | 3 |
9 | VP Shunt (proSA® Shunt System) | 8/30 | 3 |
10 | VP Shunt (proSA® Shunt System) | 6/30 | 3 |
11 | VP Shunt (M.blue plus®) | 10/34 | 2 |
12 | VP Shunt (proSA® Shunt System) | 9/36 | 5 |
13 | VP Shunt (proSA® Shunt System) | 8/28 | 0 |
14 | Explantation of VP Shunt. Exclusion of IIH. | Not Applicable | 2 |
15 | Exclusion of IIH; no treatment for IIH | Not Applicable | 0 |
16 | VP Shunt (proSA® Shunt System) | 8/20 | 3 |
17 | ETV | Not Applicable | 0 |
18 | Changes of VP Valves to proSA® Shunt System | 7/32 | 2 |
19 | VP Shunt (proSA® Shunt System) | 2/40 | 6 |
20 | VP Shunt (proSA® Shunt System) | 4/28 | 5 |
Average therapeutic shunt valve setting in the cohort | 6,3/29,8 | Total number of adjustments in all patients = 48 | |
Average therapeutic shunt valve setting excluding patients under 18 years of age | 6/30,58 | ||